{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T11:32:36Z","timestamp":1768995156827,"version":"3.49.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.intimp.2014.12.039","type":"journal-article","created":{"date-parts":[[2015,1,11]],"date-time":"2015-01-11T05:00:20Z","timestamp":1420952420000},"page":"416-422","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Macrophage-derived soluble CD163 level in young patients with Gaucher disease: Relation to phenotypes, disease severity and complications"],"prefix":"10.1016","volume":"24","author":[{"given":"Amira Abdel Moneam","family":"Adly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman Abdel Rahman","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taghreed Mahmoud","family":"Ibraheem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2014.12.039_bb0005","first-page":"3635","article-title":"Gaucher disease","volume":"vol. III","author":"Beutler","year":"2001"},{"key":"10.1016\/j.intimp.2014.12.039_bb0010","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.jpeds.2004.01.050","article-title":"Gaucher disease: lessons from a decade of therapy","volume":"144","author":"Grabowski","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.intimp.2014.12.039_bb0015","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.braindev.2005.04.005","article-title":"Type 2 Gaucher disease: 15 new cases and review of the literature","volume":"28","author":"Mignot","year":"2006","journal-title":"Brain Dev"},{"key":"10.1016\/j.intimp.2014.12.039_bb0020","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ymgme.2004.08.015","article-title":"Gaucher disease: complexity in a \u201csimple\u201d disorder","volume":"83","author":"Sidransky","year":"2004","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.intimp.2014.12.039_bb0025","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ejim.2006.07.005","article-title":"Epidemiology and natural history of Gaucher's disease","volume":"17","author":"Mehta","year":"2006","journal-title":"Eur J Intern Med"},{"issue":"1384","key":"10.1016\/j.intimp.2014.12.039_bb0030","first-page":"1386","article-title":"Home therapy for lysosomal storage disorders","volume":"16","author":"Hughes","year":"2007","journal-title":"Br J Nurs"},{"key":"10.1016\/j.intimp.2014.12.039_bb0035","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/qjmed\/94.8.407","article-title":"Lung involvement and enzyme replacement therapy in Gaucher's disease","volume":"94","author":"Goitein","year":"2001","journal-title":"QJM"},{"key":"10.1016\/j.intimp.2014.12.039_bb0040","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/820843","article-title":"Echocardiographic assessment of left ventricular function in type 1 Gaucher's disease","volume":"2010","author":"Kozelj","year":"2010","journal-title":"Adv Hematol"},{"key":"10.1016\/j.intimp.2014.12.039_bb0045","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1023\/A:1015680827730","article-title":"Failure of resting echocardiography and cardiac catheterization to identify pulmonary hypertension in two patients with type I Gaucher disease","volume":"25","author":"Sirrs","year":"2002","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.intimp.2014.12.039_bb0050","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1365-2141.2004.05351.x","article-title":"Gaucher disease: pathological mechanisms and modern management","volume":"129","author":"Jmoudiak","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.intimp.2014.12.039_bb0055","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00431-003-1362-0","article-title":"Pediatric non-euronopathic Gaucher disease: presentation, diagnosis and assessment. Consensus statements","volume":"63","author":"Grabowski","year":"2004","journal-title":"Eur J Ped"},{"key":"10.1016\/j.intimp.2014.12.039_bb0060","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1471-4906(03)00181-9","article-title":"Heme oxygenase-1: unleashing the protective properties of heme","volume":"24","author":"Otterbein","year":"2003","journal-title":"Trends Immunol"},{"key":"10.1016\/j.intimp.2014.12.039_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevImmunol.v24.i1.10","article-title":"The Scavenger Receptor Cysteine-Rich (SRCR) domain: an ancient and highly conserved protein module of the innate immune system","volume":"24","author":"Sarrias","year":"2004","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.intimp.2014.12.039_bb0070","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1046\/j.1365-2249.2002.01963.x","article-title":"Elevated levels of soluble CD163 in sera and fluids from rheumatoid arthritis patients and inhibition of the shedding of CD163 by TIMP-3","volume":"130","author":"Matsushita","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.intimp.2014.12.039_bb0075","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.imbio.2009.05.003","article-title":"Soluble macrophage-derived CD163: a homogenous ectodomain protein with a dissociable haptoglobin-hemoglobin binding","volume":"215","author":"M\u00f8ller","year":"2010","journal-title":"Immunobiology"},{"key":"10.1016\/j.intimp.2014.12.039_bb0080","doi-asserted-by":"crossref","first-page":"235461","DOI":"10.1155\/2008\/235461","article-title":"Early expression of FcgammaRI (CD64) on monocytes of cardiac surgical patients and higher density of monocyte anti-inflammatory scavenger CD163 receptor in \u201con-pump\u201d patients","volume":"2008","author":"Kolackova","year":"2008","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.intimp.2014.12.039_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2007.07.004","article-title":"The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages","volume":"66","author":"Allavena","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.intimp.2014.12.039_bb0090","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1172\/JCI117084","article-title":"Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease","volume":"93","author":"Hollak","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.intimp.2014.12.039_bb0095","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1182\/blood-2005-12-5072","article-title":"Superior effects of high-dose enzyme replacement therapy in type 1 Gaucher disease on bone marrow involvement and chitotriosidase levels: a 2-center retrospective analysis","volume":"108","author":"de Fost","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2014.12.039_bb0100","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0950-3536(97)80033-9","article-title":"Gaucher's disease: clinical features and natural history","volume":"10","author":"Cox","year":"1997","journal-title":"Baillieres Clin Haematol"},{"key":"10.1016\/j.intimp.2014.12.039_bb0105","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/(SICI)1098-1004(1997)10:5<348::AID-HUMU3>3.0.CO;2-B","article-title":"Glucocerebrosidase genotype of Gaucher patients in The Netherlands: limitations in prognostic value","volume":"10","author":"Boot","year":"1997","journal-title":"Hum Mutat"},{"key":"10.1016\/j.intimp.2014.12.039_bb0110","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00005792-199211000-00002","article-title":"Gaucher disease. Clinical, laboratory, radiologic, and genetic features of 53 patients","volume":"71","author":"Zimran","year":"1992","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.intimp.2014.12.039_bb0115","doi-asserted-by":"crossref","first-page":"209","DOI":"10.7863\/jum.1997.16.3.209","article-title":"Accuracy of ultrasonography in assessing spleen and liver size in patients with Gaucher disease: comparison to computed tomographic measurements","volume":"16","author":"Elstein","year":"1997","journal-title":"J Ultrasound Med"},{"key":"10.1016\/j.intimp.2014.12.039_bb0120","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1542\/peds.2007-0730","article-title":"Prevalence and risk factors of elevated pulmonary artery pressures in children with sickle cell disease","volume":"121","author":"Pashankar","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.intimp.2014.12.039_bb0125","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1182\/blood-2010-11-319152","article-title":"Thalassemia Clinical Research Network. Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network report","volume":"118","author":"Morris","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2014.12.039_bb0130","first-page":"1","article-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group","volume":"843","author":"World Health Organization","year":"2004","journal-title":"World Health Organ Tech Rep Ser"},{"key":"10.1016\/j.intimp.2014.12.039_bb0135","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12017-011-8147-9","article-title":"Cerebrospinal fluid microglial markers in Alzheimer's disease: elevated chitotriosidase activity but lack of diagnostic utility","volume":"13","author":"Mattsson","year":"2011","journal-title":"Neuromolecular Med"},{"key":"10.1016\/j.intimp.2014.12.039_bb0140","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1586\/epr.09.54","article-title":"Gaucher disease: a model disorder for biomarker discovery","volume":"6","author":"Boot","year":"2009","journal-title":"Expert Rev Proteomics"},{"key":"10.1016\/j.intimp.2014.12.039_bb0145","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.1016\/S0248-8663(07)78880-X","article-title":"Current development and usefulness of biomarkers for Gaucher disease follow up","volume":"28","author":"Maire","year":"2007","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.intimp.2014.12.039_bb0150","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejmhg.2011.02.008","article-title":"Outcome of enzyme replacement therapy in children with Gaucher disease: The Egyptian experience","volume":"12","author":"Khalifa","year":"2011","journal-title":"Egypt J Med Hum Genet"},{"key":"10.1016\/j.intimp.2014.12.039_bb0155","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s10545-014-9693-8","article-title":"Long-term effectiveness of enzyme replacement therapy in children with Gaucher disease: results from the NCS-LSD cohort study","volume":"37","author":"Anderson","year":"2014","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.intimp.2014.12.039_bb0160","series-title":"The online metabolic and molecular bases of inherited diseases","article-title":"Gaucher disease","author":"Grabowski","year":"2010"},{"issue":"1","key":"10.1016\/j.intimp.2014.12.039_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00365513.2011.626868","article-title":"Soluble CD163","volume":"72","author":"M\u00f8ller","year":"2012","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.intimp.2014.12.039_bb0170","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/003655102762377466","article-title":"Soluble CD163: a marker molecule for monocyte\/macrophage activity in disease","volume":"237","author":"M\u00f8ller","year":"2002","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"10.1016\/j.intimp.2014.12.039_bb0175","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.0902-4441.2003.00193.x","article-title":"Plasma level of the macrophage-derived soluble CD163 is increased and positively correlates with severity in Gaucher's disease","volume":"72","author":"M\u00f8ller","year":"2004","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.intimp.2014.12.039_bb0180","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1309\/BG5VA8JRDQH1M7HN","article-title":"Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages","volume":"122","author":"Boven","year":"2004","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.intimp.2014.12.039_bb0185","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/MBC.0b013e3283424809","article-title":"D-dimer assay in Egyptian patients with Gaucher disease: correlation with bone and lung involvement","volume":"22","author":"Sherif","year":"2011","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.intimp.2014.12.039_bb0190","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cyto.2013.12.013","article-title":"Serum levels of CD163 and TWEAK in patients with pulmonary arterial hypertension","volume":"66","author":"Jasiewicz","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2014.12.039_bb0195","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/MBC.0b013e3283573a42","article-title":"Soluble CD163 in young sickle cell disease patients and their trait siblings: a biomarker for pulmonary hypertension and vaso-occlusive complications","volume":"23","author":"Tantawy","year":"2012","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.intimp.2014.12.039_bb0200","article-title":"The clinical spectrum and pathophysiology of skeletal complications in lysosomal storage disorders","author":"Clarke","year":"2014","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.intimp.2014.12.039_bb0205","doi-asserted-by":"crossref","first-page":"A2","DOI":"10.1259\/bjr.75.suppl_1.750002","article-title":"Skeletal aspects of Gaucher disease: a review","volume":"75","author":"Wenstrup","year":"2002","journal-title":"Br J Radiol"},{"key":"10.1016\/j.intimp.2014.12.039_bb0210","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/ajh.10361","article-title":"D-dimer assay in Gaucher disease: correlation with severity of bone and lung involvement","volume":"73","author":"Shitrit","year":"2003","journal-title":"Am J Hematol"},{"key":"10.1016\/j.intimp.2014.12.039_bb0215","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.clinbiochem.2011.05.016","article-title":"Biomarkers in Serbian patients with Gaucher disease","volume":"44","author":"Sumarac","year":"2011","journal-title":"Clin Biochem"},{"key":"10.1016\/j.intimp.2014.12.039_bb0220","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1182\/blood-2003-05-1612","article-title":"Marked elevation of the chemokine CCL18\/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention","volume":"103","author":"Boot","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2014.12.039_bb0225","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1023\/A:1010514614570","article-title":"Management of neuronopathic Gaucher disease: a European consensus","volume":"24","author":"Vellodi","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.intimp.2014.12.039_bb0230","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1023\/A:1025902113005","article-title":"Advisory Council to the European Working Group on Gaucher Disease. The role of the iminosugar N butyldeoxynojirimycin (miglustat) in the management of type I (nonneuronopathic) Gaucher disease: a position statement","volume":"26","author":"Cox","year":"2003","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.intimp.2014.12.039_bb0235","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/BF00441877","article-title":"Effect of splenectomy on destructive bone changes in children with chronic (type I) Gaucher disease","volume":"145","author":"Ashkenazi","year":"2003","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.intimp.2014.12.039_bb0240","first-page":"10451064","article-title":"Evidence-based recommendations for monitoring bone disease and the response to enzyme replacement therapy in Gaucher patients","volume":"2","author":"Vom Dahl","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.intimp.2014.12.039_bb0245","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1517\/14656560903270520","article-title":"Enzyme therapy for the treatment of type 1 Gaucher disease: clinical outcomes and dose\u2013response relationships","volume":"10","author":"Hollak","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.intimp.2014.12.039_bb0250","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1189\/jlb.72.4.711","article-title":"Endotoxin induces rapid metalloproteinase-mediated shedding followed by up-regulation of the monocyte hemoglobin scavenger receptor CD163","volume":"72","author":"Hintz","year":"2002","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.intimp.2014.12.039_bb0255","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1023\/A:1012496514170","article-title":"Gaucher disease: understanding the molecular pathogenesis of sphingolipidoses","volume":"24","author":"Cox","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.intimp.2014.12.039_bb0260","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1172\/JCI0214530","article-title":"Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage","volume":"109","author":"Mizukami","year":"2002","journal-title":"J Clin Invest"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576915000053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576915000053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T19:44:40Z","timestamp":1690832680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576915000053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1567576915000053"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2014.12.039","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Macrophage-derived soluble CD163 level in young patients with Gaucher disease: Relation to phenotypes, disease severity and complications","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2014.12.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}